DaebongLS Co

DaebongLS Co Receivables

The Accounts Receivable of DaebongLS Co (078140.KQ) as of Oct 28, 2026 is 19.11 B KRW. In the previous year, Accounts Receivable was 20.67 B KRW — a change of -7.56% (lower).

Receivables

19.11 BKRW

YoY

-7.56%

Last updated:

Accounts Receivable of DaebongLS Co is 2024 19.11 B KRW. Accounts Receivable of DaebongLS Co was 2023 20.67 B KRW. It decreases by -7.56% lower compared to the previous year.

The DaebongLS Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
22.16 B KRW
Jan 1, 2018
22.31 B KRW
Jan 1, 2019
21.95 B KRW
Jan 1, 2020
19.63 B KRW
Jan 1, 2021
21.25 B KRW
Jan 1, 2022
23.19 B KRW
Jan 1, 2023
20.67 B KRW
Jan 1, 2024
19.11 B KRW
The DaebongLS Co Receivables history
YEARReceivablesYoY
19.11 BKRW-7.56%
20.67 BKRW-10.86%
23.19 BKRW+9.12%
21.25 BKRW+8.26%
19.63 BKRW-10.55%
21.95 BKRW-1.63%
22.31 BKRW+0.67%
22.16 BKRW-5.73%
23.51 BKRW+22.20%
19.24 BKRW+0.56%
19.13 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DaebongLS Co Stock analysis

What does DaebongLS Co do? DaebongLS Co., Ltd. generates revenue through the manufacturing and distribution of raw materials for pharmaceuticals and cosmetics, operating via two primary divisions. The cosmetic division supplies aloe vera gels, beta carotens, calamines, diaformers, emulgades, emulsifiers, emollients, polymers, and thickeners for various beauty and skincare products. The pharmaceutical division provides almagates, bentonites, calcitriols, erdosteines, and fish oil for antibiotics, cough products, and expectorants. The company serves domestic markets in Korea and exports to Japan, America, and Southeast Asian countries, focusing on clients in the pharmaceutical, cosmetic, and food chemical industries. DaebongLS Co., Ltd. also offers food chemical additives and fish feedstuff as part of its product portfolio, catering to additional market segments. Its customers include manufacturers requiring raw materials for pharmaceutical formulations, cosmetic product development, and food additive production. The company leverages its domestic presence in Incheon and international distribution channels to reach clients in Japan, America, and Southeast Asia, ensuring steady demand for its specialized chemical inputs. The firm’s revenue streams are derived from the sale of these specialized raw materials across multiple sectors, with a strong emphasis on pharmaceutical and cosmetic applications. Its product range supports both direct consumer goods and industrial manufacturing needs, allowing it to maintain a diversified client base. By distributing within Korea and internationally, DaebongLS Co., Ltd. ensures consistent market access for its offerings. DaebongLS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DaebongLS Co stock

Accounts Receivable of DaebongLS Co is 19.11 B KRW in 2024.

Accounts Receivable of DaebongLS Co changed from 20.67 B KRW to 19.11 B KRW, representing a -7.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable DaebongLS Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's DaebongLS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — DaebongLS Co

All Key Metrics — DaebongLS Co